Galafold
Plot twist as FDA U-turns on Amicus drug decision
July 11, 2017Research and Development, Sales and Marketing Amicus Therapeutics, FDA, Galafold
The news continues to flow out of the FDA, as it grabs another headline by backtracking on its previous decision …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
